1,146,378 Shares in Molina Healthcare, Inc $MOH Purchased by 8 Knots Management LLC

8 Knots Management LLC purchased a new position in shares of Molina Healthcare, Inc (NYSE:MOH) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 1,146,378 shares of the company’s stock, valued at approximately $198,942,000. Molina Healthcare comprises approximately 22.9% of 8 Knots Management LLC’s holdings, making the stock its biggest position.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in MOH. CenterBook Partners LP lifted its holdings in shares of Molina Healthcare by 359.7% in the 3rd quarter. CenterBook Partners LP now owns 20,409 shares of the company’s stock valued at $3,905,000 after buying an additional 15,969 shares during the period. BNP Paribas Financial Markets boosted its stake in shares of Molina Healthcare by 63.0% during the 4th quarter. BNP Paribas Financial Markets now owns 439,371 shares of the company’s stock worth $76,248,000 after acquiring an additional 169,739 shares in the last quarter. Fiera Capital Corp boosted its stake in shares of Molina Healthcare by 68.8% during the 3rd quarter. Fiera Capital Corp now owns 241,581 shares of the company’s stock worth $46,229,000 after acquiring an additional 98,431 shares in the last quarter. DDD Partners LLC purchased a new stake in shares of Molina Healthcare during the 3rd quarter worth approximately $1,743,000. Finally, Timber Creek Capital Management LLC purchased a new stake in shares of Molina Healthcare during the 3rd quarter worth approximately $4,467,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Insider Transactions at Molina Healthcare

In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the sale, the insider owned 67,175 shares in the company, valued at approximately $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total transaction of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares in the company, valued at $2,454,713.25. This represents a 4.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.44% of the company’s stock.

Molina Healthcare Trading Up 3.8%

Molina Healthcare stock opened at $200.55 on Friday. The firm’s 50-day moving average is $174.79 and its 200-day moving average is $164.50. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.63 and a current ratio of 1.63. Molina Healthcare, Inc has a 1 year low of $121.06 and a 1 year high of $311.52. The company has a market cap of $10.45 billion, a P/E ratio of 59.33 and a beta of 0.80.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The firm had revenue of $10.80 billion for the quarter, compared to analysts’ expectations of $10.91 billion. During the same quarter last year, the company posted $6.08 earnings per share. Molina Healthcare’s revenue was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, equities analysts expect that Molina Healthcare, Inc will post 5.23 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on MOH shares. JPMorgan Chase & Co. boosted their price target on Molina Healthcare from $169.00 to $191.00 and gave the stock a “neutral” rating in a research note on Monday, June 8th. Wells Fargo & Company upped their target price on Molina Healthcare from $141.00 to $159.00 and gave the company an “equal weight” rating in a research note on Monday, April 27th. Cantor Fitzgerald upped their target price on Molina Healthcare from $144.00 to $209.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Mizuho set a $215.00 price target on Molina Healthcare in a research note on Monday, June 8th. Finally, Sanford C. Bernstein reissued an “outperform” rating on shares of Molina Healthcare in a research note on Friday, March 13th. Three equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $182.73.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.